Skip to main content
OpenTrials
Completed

NCT Number: NCT03402633

Leucotrichia in Vitiligo

The incidence of leucotrichia has been reported to range from 9 to 48.4% of all vitiligo patients.Leucotrichia is more often observed in segmental vitiligo with a very high percentage. However, further studies considering the prevalence of leucotrichia in different types of vitiligo need to be conducted.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Leucotrichia

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age > 18
  • Vitiligo patients with/ without leukotrichia within the vitiliginous areas

Exclusion criteria

  • Age < 18
  • Premature hair graying in the trunk before the age of 30

Treatment and study plan

Examination of leukotrichia in vitiligo patients

Other

Examination of leukotrichia will be enhanced by wood's light and dermoscopy for better enhancing of the lesions and good magnification

Primary outcomes

  1. Detection of prevalence of leukotrichia within vitilignous areas in vitiligo patients

    Time frame: within 6 months

    Detection of prevalence of leukotrichia within vitilignous areas in vitiligo patients

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Leucotrichia in Vitiligo Patients : A Cross Sectional Study

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Jan 18, 2018
Registry last updated
Jan 18, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.